These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21599917)

  • 1. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.
    Primatesta P; Plana E; Rothenbacher D
    BMC Musculoskelet Disord; 2011 May; 12():103. PubMed ID: 21599917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
    Khanna P; Khanna D; Storgard C; Baumgartner S; Morlock R
    Postgrad Med; 2016 Jan; 128(1):34-40. PubMed ID: 26578028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
    Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
    Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gout medication treatment patterns and adherence to standards of care from a managed care perspective.
    Sarawate CA; Brewer KK; Yang W; Patel PA; Schumacher HR; Saag KG; Bakst AW
    Mayo Clin Proc; 2006 Jul; 81(7):925-34. PubMed ID: 16835972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
    Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
    Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum urate levels and gout flares: analysis from managed care data.
    Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
    J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.
    Singh JA; Akhras KS; Shiozawa A
    Arthritis Res Ther; 2015 May; 17(1):120. PubMed ID: 25963969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit restrictions and gout treatment.
    Wang SM; Aranda GA; Gao S; Patel BV
    J Manag Care Pharm; 2013; 19(9):773-82. PubMed ID: 24156646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers.
    Juge PA; Truchetet ME; Pillebout E; Ottaviani S; Vigneau C; Loustau C; Cornec D; Pascart T; Snanoudj R; Bailly F; Cornec-Le Gall E; Schaeverbeke T; Saraux A; Dieudé P; Flipo RM; Richette P; Lioté F; Bardin T; Chalès G; Ea HK
    Joint Bone Spine; 2017 Oct; 84(5):595-598. PubMed ID: 27825577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of gout in the older adult.
    Fravel MA; Ernst ME
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):271-85. PubMed ID: 21849262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gout, flares, and allopurinol use: a population-based study.
    Proudman C; Lester SE; Gonzalez-Chica DA; Gill TK; Dalbeth N; Hill CL
    Arthritis Res Ther; 2019 May; 21(1):132. PubMed ID: 31151457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GOSPEL 2 - Colchicine for the treatment of gout flares in France - a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age.
    Pascart T; Lancrenon S; Lanz S; Delva C; Guggenbuhl P; Lambert C; Aubert JP; Saraux A; Ea HK; Lioté F
    Joint Bone Spine; 2016 Dec; 83(6):687-693. PubMed ID: 26919801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
    Drivelegka P; Sigurdardottir V; Svärd A; Jacobsson LTH; Dehlin M
    Arthritis Res Ther; 2018 Jun; 20(1):108. PubMed ID: 29855389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).
    Mikuls TR; Farrar JT; Bilker WB; Fernandes S; Saag KG
    Rheumatology (Oxford); 2005 Aug; 44(8):1038-42. PubMed ID: 15870145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.
    Zandman-Goddard G; Amital H; Shamrayevsky N; Raz R; Shalev V; Chodick G
    Rheumatology (Oxford); 2013 Jun; 52(6):1126-31. PubMed ID: 23392592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of contraindications and prescription of pharmacologic therapies for gout.
    Keenan RT; O'Brien WR; Lee KH; Crittenden DB; Fisher MC; Goldfarb DS; Krasnokutsky S; Oh C; Pillinger MH
    Am J Med; 2011 Feb; 124(2):155-63. PubMed ID: 21295195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.
    Riedel AA; Nelson M; Joseph-Ridge N; Wallace K; MacDonald P; Becker M
    J Rheumatol; 2004 Aug; 31(8):1575-81. PubMed ID: 15290738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.
    Annemans L; Spaepen E; Gaskin M; Bonnemaire M; Malier V; Gilbert T; Nuki G
    Ann Rheum Dis; 2008 Jul; 67(7):960-6. PubMed ID: 17981913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Affairs Gout Cohort.
    Singh JA; Yang S; Saag KG
    J Rheumatol; 2020 Mar; 47(3):449-460. PubMed ID: 31416925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.